Author:
Grossman Madeline,Walker Stephen,Ramsey E. Zachary
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Hansmann G, Koestenberger M, Alastalo TP et al (2019) 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: the European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT. J Heart Lung Transplant 38(9):879–901. https://doi.org/10.1016/j.healun.2019.06.022
2. Kim JS, McSweeney J, Lee J, Ivy D (2016) Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: pharmacotherapies in cardiac critical care pulmonary hypertension. Pediatr Crit Care Med 17(3 Suppl 1):S89–S100. https://doi.org/10.1097/PCC.0000000000000622
3. Gorenflo M, Ziesenitz VC (2021) Treatment of pulmonary arterial hypertension in children. Cardiovasc Diagn Ther 11(4):1144–1159. https://doi.org/10.21037/cdt-20-912
4. Remodulin® (treprostinil) Injection, for subcutaneous or intravenous use [package insert]. Research Triangle Park: Unite Therapeutics Corp.; 2002
5. Veletri (epoprostenol) for Injection [package insert]. South San Francisco, CA: Actelion Pharmaceuticals US, Inc.; 1995